Human Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) ELISA Kit (96T)

Human Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) ELISA Kit (96T)

Catalog #: TD0949
Availability: In Stock
¥589.00
Detection range:  0.625-40ng/mL    
Sensitivity:  0.234ng/mL    
Type:  Traditional CDKN2A ELISA kit    
Synonyms:  P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1
Species:  Human
Sample type:  tissue homogenates, cell lysates or other biological fluids.
Experimental method:  Sandwich
Shelf life:  12 months
Gene ID:  1029
UniProt ID:  Q8N726
Components:  1. Pre-coated, ready to use 96-well strip plate 1
2. Plate sealer for 96 wells 2
3. Standard 2
4. Diluents buffer: 1×45 mL
5. Detection Reagent A: 1×120 μL
6. Detection Reagent B: 1×120 μL
7. TMB Substrate: 1×9 mL
8. Stop Solution: 1×6 mL
9. Wash Buffer (30× concentrate): 1×20 mL

 


 

Test principle

 

This gene CDKN2A generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene.

You may also be interested in the target:

CDKN2A